Loading clinical trials...
Loading clinical trials...
A Multi-Center, Open-Label, Extension Study to Allow Continued Treatment of Patients Who Have Participated in Spectrum-Sponsored Clinical Studies With Belinostat
Conditions
Interventions
Belinostat
Atazanavir
Locations
1
United States
John Wayne Cancer Institute @ Providence Saint John's Health Center
Santa Monica, California, United States
Start Date
August 5, 2019
Primary Completion Date
December 31, 2022
Completion Date
March 31, 2023
Last Updated
May 3, 2023
NCT05720117
NCT06898450
NCT06658951
NCT05223608
NCT06625775
NCT05719558
Lead Sponsor
Acrotech Biopharma Inc.
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions